Full Name
Tay, K.-G.
(not current staff)
Variants
Tay, K.G.
Tay, K.-G.
 
 
Email
mdctkg@nus.edu.sg
 
Other emails
 

Publications

Results 1-5 of 5 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J.; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
22009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J. ; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
328-Oct-2010Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibitionLeong, S.M. ; Tan, B.X.; Ahmad, B.B. ; Yan, T.; Chee, L.Y.; Ang, S.T.; Tay, K.G. ; Koh, L.P.; Yeoh, A.E.J.; Koay, E.S.-C.; Mok, Y.-K. ; Lim, T.M. 
42011PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-aml therapyZhou, J. ; Bi, C.; Chng, W.-J.; Cheong, L.-L.; Liu, S.-C.; Mahara, S. ; Tay, K.-G. ; Zeng, Q.; Li, J.; Guo, K.; Tan, C.P.B.; Yu, H. ; Albert, D.H.; Chen, C.-S.
5Feb-2011Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancersXie, Z. ; Chng, W.J.; Tay, K.G. ; Liu, S.C.; Zhou, J. ; Chen, C.-S.